We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3051
Myriad Genetics
MYGN
$391M
| $1.29K | ﹤0.01% |
146
+24
| +20% | +$288 |
2021 Q1
16 quarters
|
|
3052
DELISTED
ODP
ODP
| $1.29K | ﹤0.01% |
90
+5
| +6% | +$96 |
2022 Q2
11 quarters
|
|
3053
Ginkgo Bioworks
DNA
$691M
| $1.29K | ﹤0.01% |
226
+56
| +33% | +$571 |
2022 Q2
11 quarters
|
|
3054
Invesco WilderHill Clean Energy ETF
PBW
$293M
| $1.28K | ﹤0.01% |
82
+1
| +1% | +$19 |
2023 Q4
5 quarters
|
|
3055
Standard Lithium
SLI
$350M
| $1.27K | ﹤0.01% |
1,000
| – | – |
2021 Q4
13 quarters
|
|
3056
Magnera Corp
MAGN
$394M
| $1.25K | ﹤0.01% |
69
-7
| -9% | -$136 |
2024 Q4
1 quarter
|
|
3057
DELISTED
Jamf
JAMF
| $1.25K | ﹤0.01% |
103
-26
| -20% | -$373 |
2022 Q4
9 quarters
|
|
3058
Ivanhoe Electric
IE
$1.38B
| $1.25K | ﹤0.01% |
215
-240
| -53% | -$1.52K |
2024 Q4
1 quarter
|
|
3059
Harmonic Inc
HLIT
$1.18B
| $1.25K | ﹤0.01% |
130
+84
| +183% | +$926 |
2023 Q4
5 quarters
|
|
3060
Treace Medical Concepts
TMCI
$252M
| $1.24K | ﹤0.01% |
+148
| New | +$1.33K |
2025 Q1
0 quarters
|
|
3061
Ouster
OUST
$2.07B
| $1.24K | ﹤0.01% |
138
+28
| +25% | +$276 |
2024 Q4
1 quarter
|
|
3062
DELISTED
Soho House & Co
SHCO
| $1.24K | ﹤0.01% |
200
| – | – |
2024 Q3
2 quarters
|
|
3063
DELISTED
Vaxart
VXRT
| $1.22K | ﹤0.01% |
3,000
| – | – |
2019 Q3
22 quarters
|
|
3064
Park Aerospace
PKE
$572M
| $1.22K | ﹤0.01% |
91
-4
| -4% | -$56 |
2021 Q4
13 quarters
|
|
3065
Silvercorp Metals
SVM
$2.15B
| $1.21K | ﹤0.01% |
312
| – | – |
2024 Q3
2 quarters
|
|
3066
Sunrise Realty Trust
SUNS
$86.8M
| $1.21K | ﹤0.01% |
109
| – | – |
2024 Q3
2 quarters
|
|
3067
Ziff Davis
ZD
$1.94B
| $1.2K | ﹤0.01% |
32
-115
| -78% | -$5.52K |
2016 Q4
33 quarters
|
|
3068
DELISTED
Surmodics
SRDX
| $1.19K | ﹤0.01% |
39
-173
| -82% | -$5.83K |
2024 Q2
3 quarters
|
|
3069
Atlanta Braves Holdings Series A
BATRA
$3.47B
| $1.18K | ﹤0.01% |
27
| – | – |
2020 Q2
19 quarters
|
|
3070
Revolve Group
RVLV
$1.62B
| $1.18K | ﹤0.01% |
55
+16
| +41% | +$444 |
2023 Q3
6 quarters
|
|
3071
Applied Digital
APLD
$5.52B
| $1.18K | ﹤0.01% |
209
+187
| +850% | +$1.47K |
2024 Q4
1 quarter
|
|
3072
Aehr Test Systems
AEHR
$2.05B
| $1.17K | ﹤0.01% |
160
-71
| -31% | -$785 |
2023 Q4
5 quarters
|
|
3073
Korn Ferry
KFY
$4.04B
| $1.15K | ﹤0.01% |
17
+8
| +89% | +$540 |
2017 Q1
32 quarters
|
|
3074
Ryanair
RYAAY
$27.1B
| $1.14K | ﹤0.01% |
27
-70
| -72% | -$3.2K |
2022 Q2
11 quarters
|
|
3075
OraSure Technologies
OSUR
$251M
| $1.14K | ﹤0.01% |
338
| – | – |
2022 Q3
10 quarters
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.